BioCentury
ARTICLE | Translation in Brief

Alphamab's soup

China's Alphamab goes start to finish with antibodies

September 21, 2017 9:45 PM UTC

Chinese protein engineering company Alphamab is building a one-stop antibody production facility housing a slew of multispecific antibody-generating technologies and its own GMP plant under construction. The company has its own spin on the well-trodden territory of bispecifics production and is bringing innovation to the space with mix-mAb and nanobody platforms that can produce multiple, multifunctional antibodies in a single cell line.

According to CEO Ting Xu, Suzhou Alphamab Co. Ltd. not only plans to make a variety of antibody types but will combine antibody modules with other types of protein modules to make novel biologics. ...